Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 30566-92-8
2. 5-(n,n-dibenzylglycyl)salicylamide
3. 5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide
4. 5-((bis(benzyl)amino)acetyl)salicylamide
5. Einecs 250-244-9
6. Ec 250-244-9
7. Mls006010007
8. Schembl11197070
9. Amy8802
10. Dtxsid40184651
11. 5-(n,n-dibenzylglcyl)salicylamide
12. 5-(n,n-dibenzylglycyl) Salicylamide
13. Zinc19943219
14. 5-(dibenzylglycyl)-2-hydroxybenzamide
15. Akos015901102
16. Sb83717
17. Dibenzylamino)acetyl)-2-hydroxybenzamide
18. 5-[2-(dibenzylamino)acetyl]salicylamide
19. Smr004701089
20. Cs-0450761
21. Ft-0619916
22. W-106934
23. 5-[[bis(phenylmethyl)amino]acetyl]-2-hydroxybenzamide
| Molecular Weight | 374.4 g/mol |
|---|---|
| Molecular Formula | C23H22N2O3 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 374.16304257 g/mol |
| Monoisotopic Mass | 374.16304257 g/mol |
| Topological Polar Surface Area | 83.6 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 492 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 5-N,N-Dibenzylglycyl-Salicylamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 5-N,N-Dibenzylglycyl-Salicylamide, including repackagers and relabelers. The FDA regulates 5-N,N-Dibenzylglycyl-Salicylamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 5-N,N-Dibenzylglycyl-Salicylamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 5-N,N-Dibenzylglycyl-Salicylamide supplier is an individual or a company that provides 5-N,N-Dibenzylglycyl-Salicylamide active pharmaceutical ingredient (API) or 5-N,N-Dibenzylglycyl-Salicylamide finished formulations upon request. The 5-N,N-Dibenzylglycyl-Salicylamide suppliers may include 5-N,N-Dibenzylglycyl-Salicylamide API manufacturers, exporters, distributors and traders.
click here to find a list of 5-N,N-Dibenzylglycyl-Salicylamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 5-N,N-Dibenzylglycyl-Salicylamide DMF (Drug Master File) is a document detailing the whole manufacturing process of 5-N,N-Dibenzylglycyl-Salicylamide active pharmaceutical ingredient (API) in detail. Different forms of 5-N,N-Dibenzylglycyl-Salicylamide DMFs exist exist since differing nations have different regulations, such as 5-N,N-Dibenzylglycyl-Salicylamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 5-N,N-Dibenzylglycyl-Salicylamide DMF submitted to regulatory agencies in the US is known as a USDMF. 5-N,N-Dibenzylglycyl-Salicylamide USDMF includes data on 5-N,N-Dibenzylglycyl-Salicylamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 5-N,N-Dibenzylglycyl-Salicylamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 5-N,N-Dibenzylglycyl-Salicylamide suppliers with USDMF on PharmaCompass.
5-N,N-Dibenzylglycyl-Salicylamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 5-N,N-Dibenzylglycyl-Salicylamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 5-N,N-Dibenzylglycyl-Salicylamide GMP manufacturer or 5-N,N-Dibenzylglycyl-Salicylamide GMP API supplier for your needs.
A 5-N,N-Dibenzylglycyl-Salicylamide CoA (Certificate of Analysis) is a formal document that attests to 5-N,N-Dibenzylglycyl-Salicylamide's compliance with 5-N,N-Dibenzylglycyl-Salicylamide specifications and serves as a tool for batch-level quality control.
5-N,N-Dibenzylglycyl-Salicylamide CoA mostly includes findings from lab analyses of a specific batch. For each 5-N,N-Dibenzylglycyl-Salicylamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
5-N,N-Dibenzylglycyl-Salicylamide may be tested according to a variety of international standards, such as European Pharmacopoeia (5-N,N-Dibenzylglycyl-Salicylamide EP), 5-N,N-Dibenzylglycyl-Salicylamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (5-N,N-Dibenzylglycyl-Salicylamide USP).
LOOKING FOR A SUPPLIER?
